![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -4.88% | 1.95 | 1.90 | 2.00 | 2.05 | 1.95 | 2.05 | 1,899,144 | 14:14:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.37 | 15.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/10/2019 15:06 | We wait for the next leg up FDA approval of Accrufer and minor adjustments to the model increased our sum-of- the-parts valuation for STX to £221m or 189p per share (from £194m/166p). A commercialisation deal with a US partner will be the next major inflection point, at which point we will upgrade our model to allow for the agreed deal terms. | ![]() ny boy | |
30/10/2019 15:04 | Hello, 2theduke, wasn’t suggesting you were negative, in fact I was thinking myself why so many presentations but as I haven’t seen any serious selling, I am very positive of a successful US commercialization deal being announced this quarter, possibly next month. There are always a few sellers for any number of reasons but the levels are very low | ![]() ny boy | |
30/10/2019 14:00 | New Hardman note: | 102938cvs | |
30/10/2019 09:48 | Hi NY, the house marketing team is quite responsive and I get regular enough correspondence from them. I've not thought to approach the broker. It's not a negative comment I'm making, I just don't see the point. Especially as the original invite stated on it that "no new market information " will be provided in this update. Who knows,however I can't image why anyone would sell now - unless they think somehow that this is actually a failed commercial product that can not penetrate due to querks in doctors payments. I do not think that, for me, this should be purchased by a competitor or big co before it signs up any deals :-/ | ![]() 2theduke | |
30/10/2019 09:02 | 2theduke, are you invested here, if so from before or after the FDA rise? Maybe address your concerns to their house brokers, they are quite responsive? I’m happy to continue to hold, I have been accumulating (NFX) on pull backs but again a long term hold, somewhat interesting but obviously much more risky at this stage of their development. Dyor as usual GLA | ![]() ny boy | |
30/10/2019 06:41 | I'm not sure about the number of investor presentations. What more is there to say, and how much exposure is really going to be gained? Also, I do not think they're that popular given the above. Just seems an odd use of time, normally I would be pro management time and meetings, but here I'm just not sure of the rationale. | ![]() 2theduke | |
29/10/2019 18:31 | cranky, your chance to ask some questions... On Tuesday 12 November 2019, Shield Therapeutics (AIM: STX) is hosting an investor briefing to provide investors with an update on the Company’s progress. | ![]() ny boy | |
29/10/2019 15:21 | Knowing..Yeah since the 50p’s from memory, you finally bought in with the usual 100 shares? lol | ![]() ny boy | |
29/10/2019 10:35 | Oh I am invested. Been pushed and pushed on me that I should load up for the big gains. | ![]() knowing | |
29/10/2019 08:50 | The deals are the major news events coming up but what happened to launches in France, Spain, Ireland, Benelux, Switzerland, Scotland? WTF are Norgine doing? | ![]() crankyman | |
29/10/2019 08:25 | or both, this was boring before we took off around 100p, remember the retrace from 120p when quite a few punters got mugged after selling! | ![]() ny boy | |
28/10/2019 19:18 | Or the Chinese deal.... | ![]() nobbygnome | |
28/10/2019 18:28 | knowing, not sure if you are invested here but there is no rush, relax, do a bit of gardening, go on holiday, most of the time investing can be quite tedious, here we are just waiting for the US commercialization deal for the next leg up, which we are expecting anytime this quarter. GLA | ![]() ny boy | |
28/10/2019 14:39 | God this is boring | ![]() knowing | |
28/10/2019 11:17 | All good here MM’s occasionally mugging a few small time sellers, otherwise, majority of investors are in for the long term rewards here | ![]() ny boy | |
27/10/2019 22:39 | Arab, yep accumulating a stake to hold through the 2020’s, could grow to be a huge Company, still, early days, higher risk etc. imo | ![]() ny boy | |
25/10/2019 18:28 | Are you in nfx ny boy ? Would be surprised after your comments there today | ![]() arab3 | |
25/10/2019 17:27 | Ok Monty, Are you in NFX? Could be another Shield in the making, still early days so more risk attached. Dyor Nobby...are you in NFX? Good weekend all | ![]() ny boy | |
25/10/2019 15:00 | NY Take a look at Cambridge Cognition at 28p bought some today, market cap 6.7m peanuts, 10 bagger if works out. Let me know what you think. | ![]() montyhedge | |
25/10/2019 11:41 | The usual weird price action, sometimes not even worth checking, a bit of market rotation going on today, waiting for GE news I guess. Not that is would have much bearing on the path of this stock. Also a safe haven hold, if global markets start to unwind next month. | ![]() ny boy | |
25/10/2019 09:15 | Picked up a few more by spreadbet this morning. Such a low risk purchase.... | ![]() nobbygnome | |
25/10/2019 09:08 | 🤞🏼 | ![]() luisfrg | |
24/10/2019 15:36 | Pretty sure all the investors are clear on the story unless there will be new information | ![]() crankyman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions